ASTS
AST SpaceMobile, Inc.
ASTS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CLMB
Climb Global Solutions, Inc.
CLMB has the edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CLMB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
CLMB's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CLMB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $18.74 | -57% |
| Fair | 20x | $26.20 | -39% |
| Forward | 21x | $43.09 | — |
| Expensive | 26x | $33.59 | -22% |
| Current | 33x | $43.09 | — |
Historical ranges are pointers, not guarantees.
CLMB's PE is in its expensive range at 33x. If earnings grow as analysts expect, today's price would be 21x next year's earnings, in its fair range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CLMB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for CLMB, with profitability holding steady. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CLMB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.06 | +60% |
| Q3 2026 | $1.29 | +11% |
| Q2 2026 | $1.11 | -7.5% |
| Q1 2026 | $1.14 | +6.5% |
| Q4 2025 | $1.16 | +15% |
| Q3 2025 | $1.16 | +26% |
| Q2 2025 | $1.20 | +58% |
| Q1 2025 | $1.07 | +65% |
| Q4 2024 | $1.01 | +49% |
CLMB has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CLMB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $220.3M | +37% |
| Q2 2026 | $174.2M | +9.4% |
| Q1 2026 | $182.4M | +32% |
| Q4 2025 | $193.8M | +20% |
| Q3 2025 | $161.3M | +35% |
| Q2 2025 | $159.3M | +73% |
| Q1 2025 | $138M | +49% |
| Q4 2024 | $161.8M | +51% |
CLMB's revenue has grown year over year for 17 quarters in a row: $220M last quarter, up 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.5% | +0.2 points |
| Q2 2026 | 4.2% | -0.8 points |
| Q1 2026 | 2.1% | -1.3 points |
| Q4 2025 | 4.9% | -2.3 points |
| Q3 2025 | 4.3% | -2.8 points |
| Q2 2025 | 5% | +0.4 points |
| Q1 2025 | 3.5% | -0.3 points |
| Q4 2024 | 7.3% | +0.3 points |
CLMB has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CLMB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.1M | -50% |
| Q2 2026 | $14.9M | +$17.1M |
| Q1 2026 | $16.3M | +93% |
| Q4 2025 | -$11.9M | -174% |
| Q3 2025 | $22.2M | +$25.8M |
| Q2 2025 | -$2.2M | -130% |
| Q1 2025 | $8.5M | -40% |
| Q4 2024 | $16M | +324% |
CLMB has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CLMB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +27K shares |
| 1 year | +1% | +179K shares |
| 3 years | +3.8% | +667K shares |
| 5 years | +7% | +1.2M shares |
| Available history | +3.6% | +639K shares |
CLMB has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $182,000 |
| Q2 2026 | $146,000 |
| Q1 2026 | $1.5M |
| Q4 2025 | $320,000 |
| Q3 2025 | $307,000 |
| Q2 2025 | $540,000 |
| Q1 2025 | $883,000 |
| Q4 2024 | $555,000 |
CLMB spent $2M buying back its own shares over the past year, down 6.3% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLMB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
CLMB has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CLMB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.6 | Overbought |
| Stochastic | 84.0 | Overbought |
CLMB's weekly RSI is 79 (overbought) and its Stochastic is 84 (overbought).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CLMB PE vs Technology Sector
| Metric | CLMB | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 28x | 20% above |
| PE % | 95 | 35 | 60 pts above |
CLMB is trading at 33x earnings, a 20% premium to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CLMB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.7 | 21% above |
| 20 week MA | $30.6 | 41% above |
| 50 week MA | $26.8 | 61% above |
| 100 week MA | $28.0 | 54% above |
| 200 week MA | $21.8 | 98% above |
CLMB has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CLMB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.01 | $4.85 | +21% |
| 2021 | $4.85 | $8.92 | +84% |
| 2022 | $8.92 | $7.82 | -12% |
| 2023 | $7.82 | $13.7 | +75% |
| 2024 | $13.7 | $31.6 | +130% |
| 2025 | $31.6 | $26.0 | -18% |
| 2026 YTD | $26.0 | $43.1 | +66% |
CLMB has the edge over ASTS on returns for 2026, with the stronger performance.